Technology Review has a Q&A with Ken Offit, chief of the clinical genetics service at Memorial Sloan-Kettering Cancer Center, who is leading a new study looking for protective variants in women with mutations in BRCA2. He hopes to use SNP arrays and a large number of study participants worldwide to find what factors might protect women who are genetically predisposed to getting breast cancer from getting it.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.